CDMO Recipharm has announced an extension of its existing partnership with spray nozzle developer and manufacturer Medspray to include development of soft mist nasal delivery devices. In February 2021, Recipharm and Medspray announced the launch of their joint venture Resyca to develop soft mist inhalation products using Medspray nozzle technology. The new … [Read more...] about Recipharm and Medspray extend their partnership on Resyca SMIs to include nasal delivery
Products and Services
Inhalation Sciences and Actarmo Medical team up to offer OINDP development services
Swedish aerosol research specialists Inhalation Sciences AB (ISAB) have announced a new partnership with German OINDP development company Actarmo Medical to offer development services for inhalation products from preclinical through formulation and device development and clinical trial supplies. ISAB says that the partnership is part of a new emphasis on its … [Read more...] about Inhalation Sciences and Actarmo Medical team up to offer OINDP development services
Kindeva Drug Delivery acquires Summit Biosciences
Kindeva Drug Delivery has acquired CDMO Summit Biosciences, a nasal drug delivery specialist, the company announced. In 2020, Summit said that it had concluded a significant expansion to its facility in Lexington, KY, USA, bringing the facility to 44,000 sq ft. According to the Kindeva press release, the Summit cGMP facility in Kentucky is currently 55,000 sq ft and … [Read more...] about Kindeva Drug Delivery acquires Summit Biosciences
MDI Plus launches MDI carton that doubles as a spacer
Irish start-up MDI Plus has announced the availability of its novel metered dose inhaler carton, which can be used as a spacer. The carton/spacer includes holes in each end of the cardboard box, with an opening on one end shaped to accommodate the inhaler mouthpiece and an opening on the other end for inhalation. According to the company's web site, the carton can be … [Read more...] about MDI Plus launches MDI carton that doubles as a spacer
Oz-UK adds manufacturing line for MDIs with LGWP propellants
CRO Oz-UK has announced that it is installing a new manufacturing line for metered dose inhalers that use LGWP propellants and expects the new line to be in operation by July 2024. According to the company, the line will be able to handle both HFO-1234ze and HFA-152a solution and suspension formulations, with batch sizes of 2.5 to 10 kg. In addition to a recent … [Read more...] about Oz-UK adds manufacturing line for MDIs with LGWP propellants
Aptar Pharma opens new manufacturing facility in Mumbai
Aptar Pharma has announced the official opening of its new 7,000 sq m manufacturing facility in Mumbai, India. Aptar has been manufacturing MDI valves and pumps at the site since 2012. According to Aptar, the capabilities there "have now been expanded to offer more innovative product solutions and ensure increased manufacturing capacity to pharma customers in South … [Read more...] about Aptar Pharma opens new manufacturing facility in Mumbai
Recipharm announces appointment of Simon Gardner as Business Development Specialist, partnership with Oz-UK on LGWP MDIs
CDMO Recipharm announced that it has hired former Koura Global Business Development Director Simon Gardner as Business Development Specialist for pMDIs to assist customers with the transition to LGWP propellants. Recipharm President, Advanced Delivery Systems, Chris Hirst commented, "Vital to a successful transition for our customers is having access to a team of … [Read more...] about Recipharm announces appointment of Simon Gardner as Business Development Specialist, partnership with Oz-UK on LGWP MDIs
Kindeva and Koura partner on conversion of existing MDI to HFA 152a
Kindeva Drug Delivery and Koura Global parent company Orbia Advance Corporation announced that they have partnered to convert a currently marketed metered dose inhaler to use Koura's HFA 152a (Zephex 152a), a lower global warming potential (LGWP) propellant. According to the announcement, the collaboration "aims to facilitate conversion of pMDI products to the … [Read more...] about Kindeva and Koura partner on conversion of existing MDI to HFA 152a
FDA contracts with Aptar for LGWP propellant study
Aptar said that the company has won a contract worth up to $6 million from the FDA for a study "designed to provide the FDA with information related to the formulation, manufacture, device design and quality aspects related to low-GWP propellant MDIs and their utility to replace existing propellant MDIs." According to Aptar, the study is part of the FDA's development … [Read more...] about FDA contracts with Aptar for LGWP propellant study
1nhaler raises £2 million for development of its single-use cardboard DPI
Scottish device company 1nhaler has raised £2 million for development of a credit-card sized dry powder inhaler in a funding round led by Archangels, the investment firm announced. The 1nhaler device is made out of cardboard, contains a single dose of carrier-free API deposited on a membrane, and is breath-activated. According to the announcement, 1nhaler was … [Read more...] about 1nhaler raises £2 million for development of its single-use cardboard DPI